anavar and semaglutide FDA Approves Game-Changing Weight Loss Drug Semaglutide for Bodybuilding Without Muscle

A Fortune study found that more than 30% of patients stopped taking GLP-1 drugs after 4 weeks

Volker Spitzer, Sarah Rickwood, and Matt Stewart discuss how structured nutrition support can bridge the gap between clinical efficacy and real-world outcomes and why collaboration across pharma, nutrition, and digital health is key to long-term success

Data are shown for the full analysis set, including all randomized participants

An unhealthy gut microbiome can influence satiety hormones, inflammation, and insulin signaling GLP-1s are a mixed bag of results for your metabolic triad

The NAD+ Injection program is available at both Bare Necessities locations in Houston